Fed’s Hammack Says Bond Yield Surge Is Not Driven by Inflation Fears 
Dollar Falls as Oil Eases, Yen Jumps on Intervention Signals 
China Consumer Stocks Near Decade Lows as AI Shares Surge 
China Agrees to Buy 20 Million Tons of U.S. Coal 
Japanese Bank Stocks Surge as Bond Yields Fuel Rate Hike Bets 
Australia Unemployment Hits Five-Year High Despite Strong Jobs Growth 
Oil Prices Jump 3% as Houthi Attack Revives Supply Fears 
Gold Holds Near $4,275 as Rising Treasury Yields Fuel Fed Rate Hike Bets 
Dollar Holds Near Two-Month High as Yen Approaches 160 
Fed Unveils Stablecoin Rules Under GENIUS Act 
European Stocks Fall as Bond Yields and Geopolitical Risks Weigh 
Asian Stocks Fall as Bond Yields Surge Ahead of Trump-Xi Summit 
UK PM Burnham to Unveil Economic Vision at Labour Conference 
Gold Prices Fall as Treasury Yields Rise on Fed Rate Hike Bets 
U.S. Dollar Hits Two-Month High as Oil, Treasury Yields Surge 
US Comfortable With Canada Trade Standoff as Import Bans Loom 
Oil Prices Fall on U.S.-Iran Hormuz Deal Hopes 
Add as a preferred source on Google
Olympus Corp CEO Resigns Following Allegations
Olympus Corp, the renowned Japanese endoscope manufacturer, announced on Monday that Chief Executive Officer Stefan Kaufmann has resigned after allegations surfaced regarding his purchase of illegal drugs. This development has caused a 6% decline in the company's shares, marking the steepest drop in nearly three months.
Kaufmann, a German national, took over the CEO role in April 2023 intending to enhance Olympus's medical equipment division. He succeeded Yasuo Takeuchi, who had successfully navigated the company through extensive asset sales during his tenure.
In a company statement, Olympus disclosed that upon receiving the allegations against Kaufmann, it promptly consulted with external legal counsel and launched an investigation. The investigation's findings led the Board of Directors to unanimously conclude that Kaufmann likely engaged in behavior contrary to the company's global code of conduct and core values.
Kaufmann, 56, was asked to resign and complied with the request. As Olympus grapples with this latest scandal, Yasuo Takeuchi will temporarily reassume the CEO role.
The impact of Kaufmann's departure was evident in the stock market, as Olympus shares have seen a notable increase of 35% over the past year, outperforming the Nikkei 225 index, which rose by 24%.
This incident is not Olympus's first encounter with controversy; thirteen years ago, former CEO Michael Woodford exposed significant accounting fraud involving inflated acquisition costs to conceal financial losses. Woodford's subsequent firing sparked a turbulent battle for control of the company.
